INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
MIMEDX to Participate in Craig-Hallum 23rd Annual Institutional Investor Conference
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
Is the Options Market Predicting a Spike in MiMedx Group Stock?
MiMedx: The Hard Math Behind My Downgrade To Hold
MIMEDX Announces Launch of G4Derm® Plus
MIMEDX Announces Launch of G4Derm® Plus
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG
MiMedx Group, Inc. (MDXG) Q1 2026 Earnings Call Transcript
MiMedx (MDXG) Reports Q1 Loss, Tops Revenue Estimates
MIMEDX Announces First Quarter 2026 Operating & Financial Results
Earnings Preview: MiMedx (MDXG) Q1 Earnings Expected to Decline
MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29
MIMEDX Announces Restructuring and Cost Reduction Initiative
JPMorgan Chase & Co. Trims Stock Holdings in MiMedx Group, Inc $MDXG
MIMEDX to Sponsor Leading Advanced Wound Care Conferences
MiMedx Group (NASDAQ:MDXG) & Absci (NASDAQ:ABSI) Head to Head Analysis
MIMEDX Announces Launch of CHORIOFIX™
MiMedx Group (NASDAQ:MDXG) Hits New 1-Year Low – Here’s Why
MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields
MiMedx Group (NASDAQ:MDXG) Sets New 52-Week Low – Should You Sell?
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates
MiMedx Group, Inc. (MDXG) Q4 2025 Earnings Call Transcript
MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results
MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25
MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products
MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX®
MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel
MiMedx (MDXG) Just Flashed Golden Cross Signal: Do You Buy?
MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial
MiMedx: Breakout Setup Into A Policy Overhaul
MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule
MiMedx Group, Inc. (MDXG) Q3 2025 Earnings Call Transcript
MiMedx (MDXG) Tops Q3 Earnings and Revenue Estimates
MIMEDX Announces Record Revenue for Third Quarter 2025
MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29
MIMEDX Announces Launch of EPIXPRESS®
MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall
MiMedx Group, Inc. (MDXG) Q2 2025 Earnings Call Transcript
MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates
MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results
MIMEDX Announces Strategic Collaboration with Vaporox, Inc.
MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30
MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026
Strength Seen in MiMedx (MDXG): Can Its 8.0% Jump Turn into More Strength?